EFSD and Novo Nordisk A/S Programme for Diabetes Research in Europe
Deadline Date: 1 February 2021
The European Foundation for the Study of Diabetes (EFSD) was created by the European Association for the Study of Diabetes (EASD) to provide funding initiatives in all areas of diabetes research. The aims of EFSD are to encourage and support research in the field of diabetes, to rapidly diffuse acquired knowledge and to facilitate its application.
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: haemophilia, growth disorders and obesity. Headquartered in Denmark, Novo Nordisk employs approximately 41,600 people in 80 countries and markets its products in more than 170 countries.
Programme and Research Focus
To achieve the goals and objectives of this Programme, EFSD and Novo Nordisk invite applications by issuing this “Request for Applications” (RFA).
The EFSD/Novo Nordisk Programme for Diabetes Research in Europe will accept applications from all fields of diabetes research including both basic and clinical research.
Mechanisms of Support and Review
Research will be supported through the award of grants generally up to Euro 100,000 for basic and/or clinical research projects.
The definition of clinical research is a study performed in vivo in human individuals with focus on clinically relevant and diabetes-related topics.
Projects requiring higher funding than that specified above are also invited to apply to this Programme, i.e. applications may be submitted to complement funding for a larger project.
All projects need to provide comprehensive justification of their budget and a clear description of both, the requested amount from EFSD as well as the avialable funding for the project from other sources, if applicable (see Review Considerations).
In exceptional cases, applications for funding in an amount larger than Euro 100,000 and up to Euro 250,000 may be considered for funding. Here the additional relevant financial requirements need to be clearly justified and applicants should also indicate which part of the study will be feasible in the case of a Euro 100,000 award.
The duration of each award may be one year or longer, depending upon the needs of the project and as justified in the application.
Applications for an EFSD/Novo Nordisk grant are invited from single non-profit institutions or groups of such institutions from Europe and associated countries (for detailed country list, please see here). The principal investigator and any co-investigators must be normally employed at a non-profit institution in Europe or associated countries and the study must be performed at their place of work.
Applications will be subject to a scientific review by a specialised and independent ad hoc committee. It is anticipated that applications will be received, reviewed and approved for funding by May 2021.
Prior to any final decision on funding, and in order to offer applicants the opportunity to benefit from the review process, EFSD reserve the right to request revision to applications in accordance with the recommendations of the Review Committee.
EFSD may, at the suggestion of the Review Committee, recommend an award in a different amount from that requested, but which is considered more appropriate for the proposed studies.
Research Grant Applications
Applications for research grants may be subjected to pre-review (or triage) procedures. In this event, any application rejected at pre-review will not be subject to a complete scientific review, and no feedback report will be provided to the applicant.
The deadlines for receipt of research grant applications for funding is 1 February 2021.
All budgets are to be prepared in Euro. For countries in which the Euro is not the common currency, the exchange rate (between the Euro and the local currency in the country where the work is to be performed) used for calculating the Euro budget must be mentioned under “Budget Justification”.
Application forms may be downloaded here:
All applications must be prepared on the official forms and completed in strict accordance with the detailed instructions to be found on these forms. Applications which do not comply with the instructions given in the application form will not be considered for review.
Please send your application as one complete PDF email attachment to Foundation@easd.org by 12:00 midday (CET) on the deadline date 1 February 2021.
Completed applications will be evaluated in accordance with the criteria stated below for scientific/technical merit by an appropriate scientific committee.
Review criteria are as follows:
Reporting Requirements and Approval of Funding
All investigators funded by this Programme are required to submit a scientific progress report at the end of the project period. For those projects where funding is distributed in instalments, interim progress reports will also be required. Such reports will be subject to assessment prior to the release of any further funds.
Investigators must provide EFSD with copies of papers accepted for publication and must acknowledge the support of the Programme in all written material by use of the phrase: "supported by an EFSD/Novo Nordisk research grant".
Funded investigators are expected to be willing to serve as reviewers for EFSD in the future.
Applications for renewal of a research programme award will be accepted on a competitive basis, with the same review process as described in this Announcement. Such applications will therefore be considered in the same fashion as all other new applications received for review and without any special priority.
|Application Deadline||1 February 2021|
|Anticipated Award||May 2021|
Enquiries should be directed to:
European Foundation for the Study of Diabetes
Rheindorfer Weg 3, 40591 Düsseldorf, Germany
Tel: + 49-211-75 84 69-0
Fax: + 49-211-75 84 69 29